AlphaYou
Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 20- 52-wk high
- $27.30
- 52-wk low
- $11.92
- Prev close
- $17.94
- Mkt cap
- $5.00B
- Beta
- 1.08
- P/B
- 6.9x
Smart money
Earnings
Earnings came in 31.1% below what analysts expected.
Financials
What it sold, what it cost, what was left.
Sep 2025Dec 2025Mar 2026Jun 2026
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $0 | $0 | $0 | $0 |
| Cost of what it sold | — | $521.0K | $550.0K | — |
| Gross profit | — | -$521.0K | -$550.0K | — |
| What it spent | ||||
| Research and development | $97.2M | $95.4M | $100.9M | $152.2M |
| Sales and admin | $16.7M | $20.7M | $24.4M | $29.5M |
| Total operating expenses | $113.9M | $115.6M | $125.3M | $181.7M |
| What was left | ||||
| Operating profit | -$113.9M | -$116.1M | -$125.3M | -$181.7M |
| Interest on debt | $2.9M | $3.2M | $4.2M | $4.6M |
| Profit before tax | -$108.0M | -$112.0M | -$120.9M | -$178.6M |
| Net profit | -$108.0M | -$112.0M | -$120.9M | -$178.6M |
| EBITDA | -$104.6M | -$101.2M | -$116.1M | -$173.4M |
Technicals
Price structure
No data yet
Technicals sync when verified market data is available. No sample data is shown.
News
What the news says
28 articles · 7 days
Coverage is bullish
Tone of tracked coverage
Flputnam Investment Management Co. Makes New Investment in Dyne Therapeutics, Inc. $DYN
Leans bullishAug 18Aegis Wealth Management LLC Invests $3.33 Million in Dyne Therapeutics, Inc. $DYN
NeutralAug 18Dyne therapeutics director Jason Rhodes sells $65.2m of common stock
NeutralAug 18
